Managing Insomnia in the Primary Care Setting: Moving Towards Safer Therapies
Credit(s): 1.00 (60 min)
Release Date: Jan 09, 2020
Expiration Date: Jan 09, 2021
CME / AMA PRA Category 1 Credit™
CME / AAPA Category 1 CME Credits
MOC / ABIM MOC Part 2 Credit
CNE / Nursing Contact Hours
Insomnia is an underrecognized, undertreated, and, unfortunately, often mistreated condition, putting patients at serious health risks that are preventable with evidence-based care. For patients who do not adequately respond to cognitive behavioral therapy for insomnia, multiple pharmacologic options are available that can be tailored to specific insomnia symptoms, and newer agents have improved safety profiles over conventional hypnotics. It is vital that clinicians are able to differentiate these agents based on patient symptoms to make optimal treatment selections to meet the needs of each individual patient.
The educational program, Managing Insomnia in the Primary Care Setting: Moving Towards Safer Therapies, will reinforce the impact of insomnia on patient health, review related comorbidities, examine current and emerging therapies, and provide strategies for engaging patients in their insomnia management using a shared decision-making approach.
Welcome and Introductions
Impact of Insomnia on Patient Health and Beyond
Evidence-base Therapies for Insomnia
Engaging the Patient in Insomnia Management
Q&A Session and Activity Roundup
This activity is intended for primary care providers, including physicians, physician assistants, nurse practitioners, and relevant sub-specialty clinicians, who are on the frontlines of recognizing and diagnosing adults with insomnia.
This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.
At the conclusion of this activity, participants should be able to:
Identify the health risks and other factors associated with insomnia that indicate the need for timely and adequate assessment
Implement personalized treatment plans for patients with insomnia based on current evidence
Assess current clinical data on pharmacotherapies in development for insomnia
Develop strategies for shared decision-making with patients regarding the management of their insomnia
Physicians – This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Physicians – Boston University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please email: email@example.com.
Karl Doghramji, MD - Presenting Faculty
Professor of Psychiatry, Neurology, and Medicine
Director, Jefferson Sleep Disorders Center
Sidney Kimmel Medical College of Thomas Jefferson University
Karl Doghramji, MD is Professor of Psychiatry, Neurology, and Medicine at Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA, and Medical Director of the Jefferson Sleep Disorders Center at Thomas Jefferson University Hospital, also in Philadelphia. He is also Program Director of the Fellowship in Sleep Medicine.
Dr. Doghramji works as a clinician, researcher, educator, and physician leader, and has a national clinical and academic reputation in sleep medicine and biological psychiatry. He is actively engaged in interdisciplinary care with academic contributions in the fields of psychiatry, sleep medicine, otolaryngology, neurology, and pulmonary medicine.
Dr. Doghramji has been the recipient of 45 grants and has authored 214 academic publications (85 peer-refereed papers, 121 book chapters and electronic media publications, and 8 books) and 63 abstracts. He has also made 236 presentations at national and international scientific sessions, symposia, and courses, including the annual meetings of the American Psychiatric Association and the American Academy of Sleep Medicine. Dr. Doghramji serves as a reviewer for numerous medical journals.
An active member of many professional organizations, Dr. Doghramji has held numerous committee positions with the American Academy of Sleep Medicine and has served as an examiner for the American Board of Psychiatry and Neurology and the American Board of Sleep Medicine. In 1998, he was elected Fellow of the American Academy of Sleep Medicine; in 1994, he was elected to the American College of Psychiatrists; and, in 2017, was elected Distinguished Life Fellow of the American Psychiatric Association. He has been selected by Philadelphia Magazine for the list of "Top Doctors" for 15 years and by other, similar, publications, such as US News and World Report and Castle Connolly.
Dr. Doghramji received his medical degree from Jefferson Medical College (now Sidney Kimmel Medical College) and completed his internship in internal medicine at Presbyterian-University of Pennsylvania Medical Center in Philadelphia, his residency in psychiatry at Thomas Jefferson University Hospital, and his fellowship in sleep medicine at Albert Einstein School of Medicine in New York. He is also an Academic Associate in the Adult Division of the Institute of the Psychoanalytic Center of Philadelphia.
Paul P. Doghramji, MD
Senior Family Physician
Collegeville Family Practice
Medical Director of Health Services
Paul P. Doghramji, MD is a senior family practice physician at Collegeville Family Practice, as well as the Medical Director of Health Services at Ursinus College, both in Collegeville, PA. He is also an Attending Physician in family practice at Pottstown Memorial Medical Center in Pottstown, PA. He is past/present Co-chair for the National Sleep Foundation’s Sleep and Health Safety Course and is on the Board of Directors of the National Sleep Foundation.
Dr. Doghramji received his medical degree from Jefferson Medical College in Philadelphia, PA in 1982. He then completed his residency in family practice at Chestnut Hill Hospital in 1985. He is a member of the American Academy of Family Physicians, which awarded him a Fellowship Degree in 2005. He is also member of the Pennsylvania Academy of Family Physicians. He has received the American Medical Association’s Physician Recognition Award eight times, in every qualifying year; the last time was in 2011.
Dr. Doghramji has published more than 50 papers in peer-reviewed journals, including the American Journal of Medicine, Current Medical Research and Opinion, and Postgraduate Medicine, as well as on numerous websites on topics such as sleep disorders, gout, rheumatoid arthritis, biology of leg disorders, depression, chronic pain, health literacy, and diabetes. He is also co-author of the textbook, Clinical Management of Insomnia, recently out in its second edition.
ABIM MOC DESIGNATION STATEMENT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through BUSM’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
MIPS CREDIT DESIGNATION
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
AMERICAN ACADEMY OF FAMILY PHYSICIANS (AAFP) CREDIT
This Enduring Material activity, MANAGING INSOMNIA IN THE PRIMARY CARE SETTING Moving Towards Safer Therapies, has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 1/9/2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
JOINT PROVIDER STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Rockpointe Corporation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSING CREDIT DESIGNATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Designated for 0.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
PHYSICIAN ASSISTANT CREDIT DESIGNATION
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 1/9/2021. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES OF CONFLICTS OF INTEREST
This educational activity has been produced in adherence with the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
Faculty and Steering Committee Disclosures
The faculty and steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Karl Doghramji, MD: Consultant: Eisai, Merck, Pfizer; Stockholder: Merck
Paul P. Doghramji, MD: Advisory Board: Eisai, Jazz; Speaker’s Bureau: Allergan
Sanford Auerbach, MD (BUSM Course Director): Nothing to disclose
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Chad Williamson, MS, MBA, CMPP; Blair St. Amand; Elizabeth Drury; Natalie Sanfratello, MPH; Brian Jack, MD; PIM Planners and Managers: Nothing to disclose
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing an HTML5 video.
INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME CREDIT
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.
Jointly provided by Boston University School of Medicine, Postgraduate Institute for Medicine, and Rockpointe
This program is supported by an independent educational grant from Eisai.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS)
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.